Search…

Nanjing Pharma: Net profit in the first quarter of 2025 was 177 million yuan, an increase of 11.49% year-on-year.

29/04/2025

Nanjing Pharmaceuticals announced that its operating income for the first quarter of 2025 was 14.247 billion yuan, an increase of 2.11% year-on-year. Net profit was 177 million yuan, an increase of 11.49% year-on-year.

Latest

1 m ago

Blogger exposes fake silver jewelry and beef jerky at Huangguoshu Scenic Area, official statement issued

2 m ago

Angang Steel Co. (00347.HK) announced a net loss attributable to shareholders of approximately 554 million yuan in the first quarter, a year-on-year decrease of 66.55%.

2 m ago

China Railway Construction Corporation (00390.HK) reported a first-quarter net profit attributable to the parent company of 6.025 billion yuan, a year-on-year decrease of 19.46%.

2 m ago

Wegovy is no longer in short supply. Novo Nordisk partners with a telemedicine platform to expand sales channels.

2 m ago

Nour and Nord announced that the company will sell the drug through remote medical platforms Hims & Hers Health, Ro, and LifeMD to expand its distribution channels. Previously, due to soaring demand leading to a shortage of Wegovy supply, many patients turned to cheaper "generic versions" of Wegovy made by compounding pharmacies.

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services